High doses of intravenous vitamin C may reduce arthritic pain.
Chronic inflammation is a hallmark symptom of rheumatoid arthritis, a notion further supported by clinical evidence that subjects with rheumatoid arthritis bear higher levels of inflammation-inducing reactive oxygen species (ROS) within the body.
Any number of ROS-scavenging ingredients, then, might alleviate inflammation in those with rheumatoid arthritis. But researchers at the Riordan Clinic in Wichita, Kansas are looking at rheumatoid arthritis and vitamin C (ascorbic acid). Vitamin C isn’t just an ROS scavenger; it aids in collagen formation, and clinical trials indicate that rheumatoid arthritis sufferers often have vitamin C deficiency and low levels of vitamin C in their synovial fluid, the primary lubricant of human joints. All of this led Riordan Clinic researchers to investigate the potential for relieving rheumatoid arthritis pain with very high vitamin C doses.
In a pilot study on 11 rheumatoid arthritis patients, subjects were assigned to intravenous doses of vitamin C ranging from 7.5 g to 50 g. The primary endpoint was C-reactive protein (CRP), a marker of inflammation that dropped by an average of 44% in the nine subjects who experienced decreases.
Riordan Clinic researchers are hopeful that future arthritis research will focus on vitamin C doses and specific levels of proinflammatory cytokines.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.